Maris JM - Search Results

1

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.

Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK. Schmidt ML, et al. Among authors: maris jm. J Clin Oncol. 2005 Sep 20;23(27):6474-80. doi: 10.1200/JCO.2005.05.183. Epub 2005 Aug 22. J Clin Oncol. 2005. PMID: 16116154 Clinical Trial.

2

Familial neuroblastoma: report of a kindred with later age at diagnosis.

Lemire EG, Chodirker BN, Williams GJ, Seargeant LE, Israels SJ, Phillips SM, de Nanassy JA, Maris JM, Yanofsky RA. Lemire EG, et al. Among authors: maris jm. J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):489-93. doi: 10.1097/00043426-199809000-00017. J Pediatr Hematol Oncol. 1998. PMID: 9787327

3

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.

Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM. Guo C, et al. Among authors: maris jm. Oncogene. 1999 Sep 2;18(35):4948-57. doi: 10.1038/sj.onc.1202887. Oncogene. 1999. PMID: 10490829

4

Molecular biology of neuroblastoma.

Maris JM, Matthay KK. Maris JM, et al. J Clin Oncol. 1999 Jul;17(7):2264-79. doi: 10.1200/JCO.1999.17.7.2264. J Clin Oncol. 1999. PMID: 10561284 Review.

5

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM. Maris JM, et al. J Clin Oncol. 2000 May;18(9):1888-99. doi: 10.1200/JCO.2000.18.9.1888. J Clin Oncol. 2000. PMID: 10784629

6

Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.

Guo C, White PS, Hogarty MD, Brodeur GM, Gerbing R, Stram DO, Maris JM. Guo C, et al. Among authors: maris jm. Med Pediatr Oncol. 2000 Dec;35(6):544-6. doi: 10.1002/1096-911x(20001201)35:6<544::aid-mpo10>3.0.co;2-2. Med Pediatr Oncol. 2000. PMID: 11107113

7

BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.

Hogarty MD, Liu X, Thompson PM, White PS, Sulman EP, Maris JM, Brodeur GM. Hogarty MD, et al. Among authors: maris jm. Med Pediatr Oncol. 2000 Dec;35(6):559-62. doi: 10.1002/1096-911x(20001201)35:6<559::aid-mpo14>3.0.co;2-j. Med Pediatr Oncol. 2000. PMID: 11107117

8

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS. Thompson PM, et al. Among authors: maris jm. Cancer Res. 2001 Jan 15;61(2):679-86. Cancer Res. 2001. PMID: 11212268

9

Biological aspects of neuroblastomas identified by mass screening in Quebec.

Brodeur GM, Look AT, Shimada H, Hamilton VM, Maris JM, Hann HW, Leclerc JM, Bernstein M, Brisson LC, Brossard J, Lemieux B, Tuchman M, Woods WG. Brodeur GM, et al. Among authors: maris jm. Med Pediatr Oncol. 2001 Jan;36(1):157-9. doi: 10.1002/1096-911X(20010101)36:1<157::AID-MPO1038>3.0.CO;2-F. Med Pediatr Oncol. 2001. PMID: 11464873

10

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.

Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM. Maris JM, et al. Med Pediatr Oncol. 2001 Jan;36(1):24-7. doi: 10.1002/1096-911X(20010101)36:1<24::AID-MPO1007>3.0.CO;2-7. Med Pediatr Oncol. 2001. PMID: 11464895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters